Hepatitis C can be cured: will hepatitis B become next?

by V P Chulanov, A P Zueva, D S Kostyushev, S A Brezgin, E V Volchkova, V V Maleyev
Published 2017-11-01

Modern View on the Problem of Choosing a Vaccine against Hepatitis B

by V. P. Chulanov, T. A. Semenenko, I. V. Karandashova, S. V. Komarova, D. S. Kostyushev, A. P. Suslov, E. V. Volchkova
Published 2017-08-01

Suppression of hepatitis b virus by a combined activity of CRISPR/Cas9 and HBx proteins

by S. A. Brezgin, A. P. Kostyusheva, V. N. Simirsky, E. V. Volchkova, D. S. Chistyakov, D. S. Kostyushev, V. P. Chulanov
Published 2019-11-01

Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B

by D S Kostyushev, A P Zueva, S A Brezgin, A D Lipatnikov, V N Simirskii, D Glebe, E V Volchkova, G A Shipulin, V P Chulanov
Published 2017-11-01

Hepatitis B virus and site-specific nucleases: effects of genetic modifications in CRISPR/Cas9 on antiviral activity

by A. P. Kostyusheva, S. A. Brezgin, D. N. Zarifyan, D. S. Chistyakov, V. I. Gegechkory, E O. Bayurova, E. A. Volchkova, D. S. Kostyushev, V. P. Chulanov
Published 2019-07-01